Competition Authority imposes fines on pharmaceutical companies

The Competition Authority has decided to impose administrative fines of 155.5 million Turkish Lira on Bilim İlaç Sanayii ve Ticaret AŞ and 30.6 million Turkish Lira on Drogsan İlaçları Sanayi ve Ticaret AŞ.

According to the announcement published on the Competition Authority's website, the investigation into Bilim İlaç Sanayii ve Ticaret AŞ and Drogsan İlaçları Sanayi ve Ticaret AŞ has been concluded.

The enterprises submitted settlement texts within the scope of the investigation conducted to determine whether they had violated competition rules.

Upon this, the Board decided to impose an administrative fine of 155 million 488 thousand 332 Turkish Lira on Bilim İlaç Sanayii ve Ticaret AŞ and 30 million 593 thousand 234 Turkish Lira on Drogsan İlaçları Sanayi ve Ticaret AŞ, on the grounds that they had entered into gentlemen's agreements with competitors in the labor market not to hire each other's employees, thereby violating the Law on the Protection of Competition. Furthermore, the investigation was concluded with a settlement for the aforementioned enterprises.

On the other hand, the Board had previously imposed administrative fines of 33 million 321 thousand 564 Turkish Lira on GlaxoSmithKline İlaçları Sanayi ve Ticaret AŞ and 184 million 363 thousand 976 Turkish Lira on Abdi İbrahim İlaç Sanayi ve Ticaret AŞ within the scope of the same investigation, and had decided to conclude the investigation with a settlement for those enterprises as well.

News Source: AA